ARCHIVES

ColoPrint Improves Prognosis In Stage II and III Colon Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

NIH Eyes FCRC For Intramural Space As Contract Recompetition Planning Nears

May 23, 1980

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

September 11, 1998

In Brief: DeVita wins $150,000 Pezcoller Prize; BreastPac To “Storm” Capitol On Bastille Day For More $$

July 8, 1988

President Accepts Compromise On HEW Money Bill; Cancer Gets $523.6 Million

December 21, 1973

Nutrition, Disease Oriented Contracts

December 4, 1981

In Brief: Hong to Retire After 30 Years at MD Anderson

February 14, 2014